Aethlon Medical (NASDAQ:AEMD) Stock Passes Above 200-Day Moving Average – Here’s Why

Shares of Aethlon Medical, Inc. (NASDAQ:AEMD) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.42 and traded as high as $0.60. Aethlon Medical shares last traded at $0.57, with a volume of 1,309,468 shares trading hands.

Analysts Set New Price Targets

Several research firms recently commented on AEMD. HC Wainwright reiterated a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a research note on Friday, November 15th. StockNews.com assumed coverage on shares of Aethlon Medical in a research report on Thursday. They set a “sell” rating for the company.

Aethlon Medical Trading Up 2.9 %

The business has a 50-day moving average price of $0.41 and a 200-day moving average price of $0.42. The stock has a market cap of $7.95 million, a PE ratio of -0.20 and a beta of 1.79.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.